Sandoz has unveiled its Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF:100mg/mL), a biosimilar of reference medicine Humira, in Europe. Hyrimoz HCF is marketed in a 50mg/mL ...

The agreements are with companies that make versions of adalimumab, a drug used to treat arthritis that is known under the brand names Humira and Hyrimoz. The letter by Brown and Wyden included a ...

Reuters report added that almost 3 million Humira prescriptions have been written during the same period, although tens of thousands of scripts have started to shift to biosimilar Hyrimoz each ...

Sandoz is one such company that hopes to offer the NHS savings potential. Its Humira biosimilar, Hyrimoz, could represent savings of more than £250 million a year, according to the company ...

CVS Health has launched Cordavis, a new unit to work with manufacturers on producing biosimilar drugs for the U.S. market that cost less than their branded counterparts. Biosimilar drugs, like ...

EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASEStrong third-quarter biosimilars growth of 37% in constant ...

Sandoz recently launched Hyrimoz, a biosimilar for Humira, and has over 20 biosimilar assets in pipeline including biosimilars for Tysabri, Prolia/Xgeva, Stelara, and Eylea. In Europe and other ...

Almost 3 million Humira prescriptions have been written during the same period, although tens of thousands of scripts have started to shift to biosimilar Hyrimoz each week since CVS Health's ...

The agreements are with companies that make versions of adalimumab, a drug used to treat arthritis that is known under the brand names Humira and Hyrimoz. The letter by Brown and Wyden included a ...

In recent months, we received approval for Pyzchiva® and Enzeevu™ in the US, launched Pyzchiva® in Europe and see continued strong uptake of Hyrimoz® in the US. “Net sales growth was ...